Huai Qi Huang potentiates dexamethasone- mediated lethality in acute lymphoblastic leukemia cells by upregulating glucocorticoid receptor α

6Citations
Citations of this article
7Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Background: Glucocorticoids are important components of a number of chemotherapeutic regimens used to treat pediatric acute lymphoblastic leukemia (ALL). A primary cause of treatment failure of ALL is acquired resistance to glucocorticoids. Recently, traditional Chinese medicines were effectively used to treat solid tumors. Thus, the aim of this study was to investigate whether Huai Qi Huang (HQH), a traditional Chinese medicine, increased the efficacy of glucocorticoids in the treatment of ALL, and if so, to determine the underlying mechanism. Material/Methods: Various concentrations of HQH were used to treat Jurkat and Nalm-6 cells for 24 to 72 hours. Subsequently, cells were co-treated with HQH and the glucocorticoid receptor agonist, dexamethasone (DEX), or a MEK inhibitor (PD98059) to verify the synergistic effects on apoptosis in Jurkat and Nalm-6 cells for 24 hours. Cell Counting Kit-8 assay and flow cytometry were used to measure cell viability and apoptosis, respectively. Protein and mRNA expression levels were assessed using western blotting and quantitative polymerase chain reaction. Results: The results revealed that cell survival was reduced and apoptosis was increased as the HQH concentration was increased, and this was accompanied with increases in the levels of BAX, cleaved-caspase-3 and glucocorticoid receptor α (GRα) and decreases in the levels of Bcl-2 and phospho-ERK (pERK). Glucocorticoid receptor β (GRβ) and total ERK (t-ERK) had no significant changes. Combined treatment with HQH and DEX or PD98059 increased apoptosis in Jurkat and Nalm-6 cells, and concurrently increased BAX, cleaved-caspase-3, GILZ, NFKBIA, and GRa and decreased Bcl-2 and pERK. Conclusions: HQH enhanced the sensitivity of ALL cells to glucocorticoids by increasing the expression of GRa and inhibiting the MEK/ERK pathway, thus providing a rational foundation for the treatment of ALL with HQH.

References Powered by Scopus

Targeting RAS signalling pathways in cancer therapy

2716Citations
N/AReaders
Get full text

IAP proteins: Blocking the road to death's door

1619Citations
N/AReaders
Get full text

The RSK family of kinases: Emerging roles in cellular signalling

622Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Immunoregulatory effects of Huaier (Trametes robiniophila Murr) and relevant clinical applications

9Citations
N/AReaders
Get full text

Exploring the nexus of nuclear receptors in hematological malignancies

4Citations
N/AReaders
Get full text

Electroacupuncture and moxibustion-like stimulation activate the cutaneous and systemic hypothalamic–pituitary–adrenal axes in the rat

3Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Xu, W., Wang, Z., Li, K., & Jin, R. (2020). Huai Qi Huang potentiates dexamethasone- mediated lethality in acute lymphoblastic leukemia cells by upregulating glucocorticoid receptor α. Medical Science Monitor, 26. https://doi.org/10.12659/MSM.921649

Readers over time

‘20‘21‘2302468

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 1

50%

Researcher 1

50%

Readers' Discipline

Tooltip

Pharmacology, Toxicology and Pharmaceut... 2

50%

Medicine and Dentistry 1

25%

Biochemistry, Genetics and Molecular Bi... 1

25%

Save time finding and organizing research with Mendeley

Sign up for free
0